Bridging the gap between innovation and capital
Elanco Animal Health
Focus on Therapeutic Biotech Companies
Program
Calling all biotech companies to apply to pitch to Elanco Animal Health.
Calling all biotech companies! Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society at large. Elanco actively pursues and cultivates partnerships with a diverse range of companies and organizations globally, all of which aim to advance its vision and enhance their commitment to animal health.
As a spin-off from Eli Lilly, Elanco brings unparalleled expertise, extensive market reach, and a deep commitment to partnerships, making them the ideal collaborator for early-stage companies ready to make an impact. Elanco’s approach combines robust internal R&D with strategic collaborations across the biotech ecosystem — including startups and venture partners — to accelerate the development of transformative solutions. If your biotech company is developing therapeutics with crossover potential into veterinary applications, now is the time to apply to Investor Connect.
Event
LaunchBio and Silicon Valley Bank, a division of First Citizens Bank, are pleased to announce their next Investor Connect virtual event with Elanco Animal Health.
Applications will be selected based on meeting the following criteria:
Geography:
Global
Areas of Interest:
- Therapeutics
- Biologics/ Vaccines
- Small and large molecules
Research areas of interest include, but are not limited to:
- Therapeutic agents for managing acute and chronic diseases in pets (dogs and cats), such as osteoarthritis, atopic dermatitis, diabetes, and chronic kidney disease
- Immunomodulation
- Pain & Inflammation
- Dermatology
- Renal
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Silicon Valley Bank, a division of First Citizens Bank.